Sfoglia per Autore
Vasculoprotective function of HDL from CETP-deficient subjects
2013 A. Ossoli, M. Gomaraschi, S. Pozzi, P. Nilsson P, W. Jessup, J.A. Kuivenhoven, R. Spina, V. Valenti, B. Cefalù, M.R. Averna, C.R. Sirtori, G. Franceschini, L. Calabresi
Effects of multiple infusions of recombinant LCAT on plasma and tissue lipids and expression of genes involved in atherogenesis
2013 B.V.X. Rousset, B.J. Auerbach, B.R. Krause, R. Homan, L. Freeman, A. Ossoli, M.L.S. Lsampson, A.T. Remaley
Role of Lecithin: Cholesterol Acyltransferase in HDL Metabolism and Atherosclerosis
2013 L. Ahsan, A.F. Ossoli, L. Freeman, B. Vaisman, M.J. Amar, R.D. Shamburek, A.T. Remaley
Off-target effects of thrombolytic drugs : apolipoprotein A-I proteolysis by alteplase and tenecteplase
2013 M. Gomaraschi, A. Ossoli, C. Vitali, S. Pozzi, L. Vitali Serdoz, C. Pitzorno, G. Sinagra, G. Franceschini, L. Calabresi
Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome
2013 M. Gomaraschi, A. Ossoli, E. Favari, M. Adorni, G. Sinagra, L. Cattin, F. Veglia, F. Bernini, G. Franceschini, L. Calabresi
Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency
2013 S. Simonelli, C. Tinti, L. Salvini, L. Tinti, A. Ossoli, C. Vitali, V. Sousa, G. Orsini, M.L. Nolli, G. Franceschini, L. Calabresi
HDL and endothelial protection : examining evidence from HDL inherited disorders
2013 M. Gomaraschi, A. Ossoli, C. Vitali, L. Calabresi
Genetic determinants of HDL metabolism
2014 A. Ossoli, M. Gomaraschi, G. Franceschini, L. Calabresi
Hepatic ACAT2 knock down increases ABCA1 and modifies HDL metabolism in mice
2014 M. Pedrelli, P. Davoodpour, C. Degirolamo, M. Gomaraschi, M. Graham, A. Ossoli, L. Larsson, L. Calabresi, J. Gustafsson, K.R. Steffensen, M. Eriksson, P. Parini
LCAT deficiency does not impair amyloid metabolism in APP/PS1 mice
2014 S. Stukas, L. Freeman, M. Lee, A. Wilkinson, A. Ossoli, B. Vaisman, S. Demosky, J. Chan, V. Hirsch-Reinshagen, A.T. Remaley, C.L. Wellington
ROLE OF ABNORMAL LIPOPROTEINS IN ATHEROSCLEROSIS AND RENAL DISEASE IN LCAT DEFICIENCY
2014 A.F. Ossoli
eNOS activation by HDL is impaired in genetic CETP deficiency
2014 M. Gomaraschi, A. Ossoli, S. Pozzi, P. Nilsson, A.B. Cefalù, M. Averna, J.A. Kuivenhoven, G..K. Hovingh, F. Veglia, G. Franceschini, L. Calabresi
Familial LCAT deficiency : from pathology to enzyme replacement therapy
2015 A. Ossoli, F. Lucca, G. Boscutti, A.T. Remaley, L. Calabresi
The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties
2015 A. Schwendeman, D.O. Sviridov, W. Yuan, Y. Guo, E.E. Morin, Y. Yuan, J. Stonik, L. Freeman, A. Ossoli, S. Thacker, S. Killion, M. Pryor, Y..E. Chen, S. Turner, A.T. Remaley
Fenofibrate and extended-release niacin improve the endothelial protective effects of HDL in patients with metabolic syndrome
2015 M. Gomaraschi, A. Ossoli, M.P. Adorni, E. Damonte, E. Niesor, F. Veglia, G. Franceschini, R. Benghozi, L. Calabresi
Deficit di lecitina:colesterolo aciltransferasi: dalla genetica alla terapia
2016 F. Lucca, A. Ossoli, G. Boscutti, G. Franceschini, L. Calabresi
Plasma-derived and synthetic high-density lipoprotein inhibit tissue factor in endothelial cells and monocytes
2016 A. Ossoli, A.T. Remaley, B. Vaisman, L. Calabresi, M. Gomaraschi
Role of LCAT in atherosclerosis
2016 A. Ossoli, S. Simonelli, C. Vitali, G. Franceschini, L. Calabresi
Lipoprotein X causes renal disease in LCAT deficiency
2016 A. Ossoli, E.B. Neufeld, S.G. Thacker, B. Vaisman, M. Pryor, L.A. Freeman, C.A. Brantner, I. Baranova, N.O. Francone, S.J. Demosky, C. Vitali, M. Locatelli, M. Abbate, C. Zoja, G. Franceschini, L. Calabresi, A.T. Remaley
High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis
2016 A. Ossoli, C. Pavanello, L. Calabresi
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile